12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Deciphera Pharmaceuticals (NASDAQ:DCPH) stock rose 71.0% to $25.05 during Monday’s pre-market session. The market value of their…
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Shares of Koninklijke Philips N.V. (NYSE:PHG) rose sharply in today’s pre-market trading after reporting first-quarter results. The company…
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Why Is European Healthcare Tech Giant Philips Stock Trading Higher On Wednesday?
Philips has finalized an agreement with US authorities and the FDA regarding the recall of Respironics ventilators. Consent decree mandates remediation prioritization and operational focus in the US. Business outlook and financial guidance remain stable.
Competitor Exit A Boom For Respiratory Device-Focused Inogen, Earns Analyst Upgrade
Impact of Philips' decision to halt CPAP device sales in the U.S. and its potential market implications. William Blair sees a significant opportunity for Inogen to reclaim market share.
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering.
Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20.
Dutch Health Tech Firm Philips Stops US Sales Of Respiratory Devices Under Finalized Consent Decree Over Device Recall
Philips' Q4 earnings and FDA settlement insights. Learn about the consent decree, actions, future plans for Philips Respironics in the U.S. International services remain unaffected. Philips' 2024 forecasts and financial outlook.
Philips Reports Q4 Results, Joins Ryanair And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday.
Earnings Scheduled For January 29, 2024
Companies Reporting Before The Bell
• Koninklijke Philips (NYSE:PHG) is expected to report quarterly earnings at $0.63 per share on revenue of $5.79 billion.